| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b12f0d44fedff92f970fb40a547058be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8528ff66470c896b6da8ed059464e31f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-569 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2851
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1027 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate |
2013-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7bed729d84713b33c1370749da204e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe40fe10972e148333cc899ee60e912d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c521d66a735213870db6422ac0c226d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff70addc275f753edc0e1aa5af9b68ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e257c6ec793c2e76c369df5ab8c6d09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25d6d0e78fa907a283ac9114272ebf8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67ed15a842cd05ac1beedd1a50cc6af8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bf5336ea64e3e9c752bb2edd647a56c |
| publicationDate |
2017-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2013265665-B2 |
| titleOfInvention |
Anti-macrophage mannose receptor single variable domains for targeting and in vivo imaging of tumor-associated macrophages |
| abstract |
The present invention relates to immunoglobulin single variable domains directed against human macrophage mannose receptor (MMR) and their uses in the field of oncology. More specifically, it concerns immunoglobulin single variable domains, including nanobodies, against human MMR and their use in targeting and in vivo imaging of tumor-associated macrophages, with applications in the field of cancer diagnostics and therapeutics and monitoring of the disease. |
| priorityDate |
2012-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |